|
WO2020249079A1
|
|
Shp2 phosphatase allosteric inhibitor
|
|
WO2017133630A1
|
|
Inhibitor of bruton's tyrosine kinase
|
|
WO2016127925A1
|
|
Drug combination of flavonoid compound and use of same
|
|
WO2015014284A1
|
|
Method for treating breast cancer
|
|
WO2015010596A1
|
|
Prognosis diagnosis method of breast cancer
|
|
EP2808016A1
|
|
Use of icaritin for the preparation of a composition for treating cancer
|
|
WO2014146575A1
|
|
Antibodies and methods for treating estrogen receptor-associated diseases
|
|
WO2011047597A1
|
|
Dihydroxy benzopyranone compounds, medical compositions thereof, and their use for treating and preventing fracture and osteoporosis
|
|
WO2011047596A1
|
|
Use of hydroxy benzopyrone compounds for preparing medicine useful for for precaution and treatment of fracture and osteoporosis
|
|
WO2011047595A1
|
|
Use of hydroxy benzopyrone compounds in preparing medicine useful for treating leukemia
|
